Nordwest Krankenhaus
Nordwest Krankenhaus
Deutschland, Frankfurt am Main
Elke Jaeger
41 Jahre der Erfahrung
Klinik ist zertifiziert :
Die Gesamtkosten für die Behandlung von Hodgkin-Lymphom in Deutschland variieren je nach den spezifischen Verfahren und Konsultationen, die erforderlich sind. Eine Online-Konsultation mit einem Hämatologie-Spezialisten kostet 610 €, während eine Radio-Onkologie-Konsultation gefolgt von einer Videokonsultation 1.080 € kostet. Darüber hinaus kostet ein Knochenmarktransplantationsverfahren 234.780 €. Der Behandlungsplan wird nach einer detaillierten Bewertung durch das medizinische Team personalisiert.
| Deutschland | Türkei | Österreich | |
| Strahlentherapie bei Darmkrebs | von $20,000 | von $7,000 | von $12,000 |
| Immuntherapie mit Keytruda (Pembolizumab) | von $10,000 | von $3,300 | von $15,000 |
| Chemotherapie bei Brustkrebs | von $4,500 | von $1,200 | von $15,000 |
| Chemotherapie | von $1,152 | von $2,430 | von $2,500 |
| Biologische Therapie | von $12,000 | von $5,500 | von $20,000 |
Ph.D. Viola Fox leitet die Klinik für Hämatologie, Onkologie und Palliativmedizin am BKZ Solingen – einem zertifizierten interdisziplinären Krebszentrum.
Prof. Dr. med. Elke Jäger hat über 1.100 onkologische Eingriffe durchgeführt und wird vom Focus als eine der Top-Onkologinnen Deutschlands geführt.
1.100 Lymphom-Eingriffe durchgeführt – Prof. Weidmann leitet die Hämatologie am Krankenhaus Nordwest, einem führenden Zentrum für Bluterkrankungen.
Leiter des Zentrums für Knochenmarktransplantation am Universitätsklinikum Essen – spezialisiert auf die Behandlung des Hodgkin-Lymphoms.
Germany is a global leader in Hodgkin lymphoma care due to the German Hodgkin Study Group (GHSG) protocols. These research-driven standards prioritize high survival rates while reducing treatment toxicity. German university hospitals provide access to advanced PET-guided therapy and innovative immunotherapies for complex cases.
Bookimed Expert Insight: While many countries follow standard Chemotherapy, German centers like Nordwest Clinic integrate research institutes directly into patient care. This allows patients to access innovative anticancer vaccines and targeted immunology before they reach global markets. Prof. Dr. Elke Jaeger at Nordwest brings over 35 years of oncology expertise to these advanced protocols.
Patient Consensus: Patients value how quickly they can secure appointments for second opinions and pathology re-reviews. They often choose Germany to confirm their diagnosis before starting intensive treatment to ensure the plan is protocol-driven.
Stem cell transplants and CAR-T cell therapies are available at specialized German medical centers. Academic institutions and certified oncology clinics offer autologous and allogeneic procedures. These therapies are strictly regulated by the Federal Institute for Drugs and Medical Devices to ensure safety and quality.
Bookimed Expert Insight: Patient volume serves as a critical quality indicator in Germany. Essen University Hospital and the University Hospital in Dusseldorf serve over 350,000 patients annually. High-volume centers often possess more extensive experience with cellular therapy toxicities. This infrastructure support is vital for managing complex recovery phases effectively.
Patient Consensus: Patients emphasize that while these treatments are available, they are concentrated in major academic centers. It is important to confirm upfront if a center has a dedicated transplant unit and handles insurance approvals for cellular therapies.
German oncology centers treat intermediate-stage Hodgkin lymphoma with the 2+2 protocol (ABVD/eBEACOPP) and advanced cases with the BrECADD regimen. These protocols, developed by the German Hodgkin Study Group (GHSG), utilize interim PET scans to adapt treatment intensity and reduce long-term toxicity.
Bookimed Expert Insight: German clinics like Nordwest and Essen University Hospital prioritize the BrECADD regimen because it maintains a 94% 4-year progression-free survival rate. Historically, intensive eBEACOPP was the standard, but our data shows a shift toward BrECADD to protect patient fertility and heart health. This protocol effectively eliminates the need for radiation in roughly two-thirds of advanced-stage patients.
Patient Consensus: Patients note that German oncologists often suggest more intensive regimens like BEACOPP earlier than expected. Many emphasize the importance of discussing fertility preservation before starting these specific chemotherapy cycles.
Hodgkin's lymphoma patients in Germany anticipate side effects like bone marrow suppression, nausea, and long-term organ toxicity. German protocols utilize PET-guided therapy to reduce toxic exposure. Management focuses on preventing infections and protecting fertility through specialized national networks and structured lifetime follow-up care.
Bookimed Expert Insight: German university hospitals like Essen and Dusseldorf represent a high concentration of research-driven care. This environment is crucial because complex lymphoma cases benefit from the 30+ specialized institutes often found within a single German medical complex. These centers integrate innovative drug therapy and molecular diagnostics, which are managed by high-volume experts like Prof. Elke Jaeger, who oversees 61,000 yearly patients at Nordwest Clinic.
Patient Consensus: Patients emphasize that fatigue and steroid-related mood changes can be more disruptive than nausea. They recommend starting a bowel regimen early and monitoring blood counts closely to prevent fever-related emergencies.
Identify the best German hospital for Hodgkin’s lymphoma by selecting institutions with German Cancer Society (DKG) certification. Seek centers participating in the German Hodgkin Study Group (GHSG) for advanced protocols. Verify the presence of dedicated hematology units and PET-CT staging capabilities.
Bookimed Expert Insight: Patient volume is a major indicator of success in complex hematology. For example, Essen University Hospital serves 370,000 patients annually and features a dedicated Bone Marrow Transplant Center. Choosing a high-volume academic facility over a smaller regional clinic ensures exposure to rare relapsed cases and access to newer immunotherapies like Keytruda.
Patient Consensus: Patients emphasize the need for a second pathology opinion to confirm the exact lymphoma subtype. It is also important to choose a facility where an international office is available to manage language barriers and logistics.